JAMES F YOUNG Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JAMES F YOUNG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAMES F YOUNG. JAMES F YOUNG is President, R&D in MEDIMMUNE INC /DE ($MEDI) and Director in NOVAVAX INC ($NVAX).
Latest Insider Trading Transactions of JAMES F YOUNG
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Option Exercise | A | 0.00 | 1,400 | 0 | 1,400 | |
| Jun 22 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Option Exercise | A | 179.89 | 2,600 | 467,714 | 2,600 | |
| Mar 25 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Option Exercise | M | 3.99 | 37,500 | 149,438 | 0 | |
| Mar 25 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Option Exercise | M | 27.60 | 10,000 | 276,000 | 0 | |
| Mar 25 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Option Exercise | M | 46.00 | 10,000 | 460,000 | 0 | |
| Mar 25 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Buy | M | 3.99 | 37,500 | 149,438 | 57,500 | 20 K to 57.5 K (+187.50 %) |
| Mar 25 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Buy | M | 27.60 | 10,000 | 276,000 | 20,000 | 10 K to 20 K (+100.00 %) |
| Mar 25 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Sell | S | 229.41 | 2,446 | 561,134 | 10,000 | 12.4 K to 10 K (-19.65 %) |
| Mar 25 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Sell | S | 228.42 | 3,120 | 712,661 | 12,446 | 15.6 K to 12.4 K (-20.04 %) |
| Mar 25 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Sell | S | 227.43 | 4,434 | 1,008,435 | 15,566 | 20 K to 15.6 K (-22.17 %) |
| Mar 25 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Buy | M | 46.00 | 10,000 | 460,000 | 20,000 | 10 K to 20 K (+100.00 %) |
| Jan 05 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Option Exercise | M | 0.00 | 10,000 | 0 | 10,000 | |
| Jan 05 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Option Exercise | M | 51.40 | 10,000 | 514,000 | 0 | |
| Jan 05 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Option Exercise | M | 50.00 | 1,000 | 50,000 | 0 | |
| Jan 05 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Buy | M | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Jan 05 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Sell | S | 113.60 | 2,000 | 227,190 | 0 | 2 K to 0 (-100.00 %) |
| Jan 05 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Sell | S | 112.98 | 9,000 | 1,016,825 | 2,000 | 11 K to 2 K (-81.82 %) |
| Jan 05 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Buy | M | 51.40 | 10,000 | 514,000 | 11,000 | 1,000 to 11 K (+1,000.00 %) |
| Jan 05 2021 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Buy | M | 50.00 | 1,000 | 50,000 | 1,000 | 0 to 1,000 |
| Dec 08 2020 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
| Jun 26 2020 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Option Exercise | A | 0.00 | 7,590 | 0 | 7,590 | |
| Jun 26 2020 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Option Exercise | A | 83.54 | 15,180 | 1,268,137 | 15,180 | |
| Jun 26 2020 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Option Exercise | A | 0.00 | 7,590 | 0 | 7,590 | |
| Jun 26 2020 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Option Exercise | A | 83.54 | 15,180 | 1,268,137 | 15,180 | |
| Jun 05 2020 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Buy | P | 48.83 | 1,500 | 73,245 | 1,500 | 0 to 1.5 K |
| Dec 16 2019 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Option Exercise | A | 3.99 | 40,000 | 159,600 | 40,000 | |
| Dec 14 2018 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Option Exercise | A | 2.30 | 200,000 | 460,000 | 200,000 | |
| Dec 19 2017 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Option Exercise | A | 1.38 | 200,000 | 276,000 | 200,000 | |
| Sep 01 2017 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Sell | S | 1.06 | 175,000 | 184,870 | 0 | 175 K to 0 (-100.00 %) |
| Mar 20 2017 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Option Exercise | A | 1.38 | 200,000 | 276,000 | 200,000 | |
| Mar 16 2017 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Sell | S | 1.39 | 100,000 | 138,980 | 175,000 | 275 K to 175 K (-36.36 %) |
| Mar 17 2016 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Option Exercise | A | 4.99 | 100,000 | 499,000 | 100,000 | |
| Jun 22 2015 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Sell | S | 9.47 | 50,000 | 473,615 | 375,000 | 425 K to 375 K (-11.76 %) |
| Mar 09 2015 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Option Exercise | A | 8.94 | 100,000 | 894,000 | 100,000 | |
| Mar 10 2004 | MEDI | MEDIMMUNE INC /DE | YOUNG JAMES F | President, R&D | Option Exercise | A | 23.45 | 200,000 | 4,690,000 | 200,000 |
Page: 1